2 terminated, 1 completed. 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 3 | Terminated 2, Completed 1 |
Follow RFT5-SMPT-dgA immunotoxin: new trials by email Literature Review of RFT5-SMPT-dgA immunotoxin trials Research Report on RFT5-SMPT-dgA immunotoxin
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Phase II Study Of Imtox-25 In Adults With Refractory/Relapsed Cd25 Positive Adult T Cell Leukemia/Lymphoma IMTOX-25 - Adult T Cell Leukemia, Adult T Cell Lymphoma | Phase 2 | Terminated | Amit Verma | 1 | 2010-09-01 | 2023-06-09 |
| RFT5-dgA Immunotoxin in Treating Patients With Relapsed or Refractory Cutaneous T-Cell Non-Hodgkin Lymphoma RFT5-dgA immunotoxin, fluorescence activated cell sorting, immunohistochemistry staining method - Lymphoma | Phase 2 | Terminated | University of Texas Southwestern Medical Center | 1 | 2008-11-07 | 2018-12-14 |
| Selective T-Cell Depletion to Reduce GVHD (Patients) Receiving Stem Cell Tx to Treat Leukemia, Lymphoma or MDS RFT5-SMPT-dgA, Isolex system - Graft vs Host Disease, Myelodysplastic Syndromes | Phase 2 | Completed | National Heart, Lung, and Blood Institute (NHLBI) | 23 | 2001-05-01 | 2016-10-28 |
Lymphoma (3) · Leukemia (2) · Anemia, Refractory, with Excess of Blasts (1) · Graft vs Host Disease (1) · Hodgkin Disease (1) · Leukemia, Lymphocytic, Chronic, B-Cell (1) · Leukemia, Lymphoid (1) · Leukemia, Myelogenous, Chronic, BCR-ABL Positive (1) · Leukemia, Myeloid (1) · Leukemia, Myeloid, Acute (1) · Leukemia, Myelomonocytic, Chronic (1) · Lymphoma, Mantle-Cell (1) · Lymphoma, Non-Hodgkin (1) · Lymphoma, T-Cell, Cutaneous (1) · Mycosis Fungoides (1)
Amit Verma (1) · National Heart, Lung, and Blood Institute (NHLBI) (1) · University of Texas Southwestern Medical Center (1)
United States (3)
A. J Barrett, MD (1) · Samir Parekh, MD (1) · Simrit Parmar, MD (1)